January – March 2021 | New Safety Information or Potential Signals of

by Pill Pals Pharmacy Team | Jun 13, 2026 | News From Around The Web

Addyi (flibanserin)Drug hypersensitivity The “Contraindications”, “Warnings and Precautions”, “Adverse Reactions”, and “Medication Guide” sections of the labeling were updated in September 2021 to include...

Blood Research

by Pill Pals Pharmacy Team | Jun 13, 2026 | News From Around The Web

The following are a listing of blood research projects:Biochemistry & Vascular BiologyCellular HematologyMolecular VirologyEmerging Pathogens Content current as of: 06/12/2026...

July – September 2024 | New Safety Information or Potential Signals of

by Pill Pals Pharmacy Team | Jun 13, 2026 | News From Around The Web

The drug product(s) included in any of the potential signals of serious risks/new safety information listed below may also include the generic version of the drug product(s), if there are generic versions approved for use by the FDA at the time of this...

Tissue and Advanced Therapies Research

by Pill Pals Pharmacy Team | Jun 13, 2026 | News From Around The Web

Tissue & Advanced Therapies Research | FDA Source

April – June 2024 | New Safety Information or Potential Signals of Ser

by Pill Pals Pharmacy Team | Jun 13, 2026 | News From Around The Web

The drug product(s) included in any of the potential signals of serious risks/new safety information listed below may also include the generic version of the drug product(s), if there are generic versions approved for use by the FDA at the time of this...

January – March 2024 | New Safety Information or Potential Signals of

by Pill Pals Pharmacy Team | Jun 13, 2026 | News From Around The Web

Akeega (niraparib and abiraterone acetate)Zejula (niraparib)HaemorrhageFDA is evaluating the need for regulatory action.Certain amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate and dextroamphetamine sulfate (generic product) Lack of...